Hollsteen
← VeriSign

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 2016: $15.0M · 10-Q 0001014473-16-000101 filed Apr 28, 2016D&A · Q2 2016: $15.0M · derived · 10-Q 0001014473-17-000029 filed Jul 27, 2017D&A · Q3 2016: $15.0M · derived · 10-Q 0001014473-17-000048 filed Oct 26, 2017D&A · Q4 2016: $14.0M · derived · 10-K 0001014473-18-000018 filed Feb 16, 2018D&A · Q1 2017: $13.0M · 10-Q 0001014473-17-000012 filed Apr 27, 2017D&A · Q2 2017: $12.0M · derived · 10-Q 0001014473-18-000036 filed Jul 26, 2018D&A · Q3 2017: $12.0M · derived · 10-Q 0001014473-18-000040 filed Oct 25, 2018D&A · Q4 2017: $12.0M · derived · 10-K 0001014473-19-000005 filed Feb 15, 2019D&A · Q1 2018: $12.0M · 10-Q 0001014473-18-000028 filed Apr 26, 2018D&A · Q2 2018: $12.0M · derived · 10-Q 0001014473-19-000030 filed Jul 25, 2019D&A · Q3 2018: $12.0M · derived · 10-Q 0001014473-19-000037 filed Oct 24, 2019D&A · Q4 2018: $12.0M · derived · 10-K 0001014473-20-000006 filed Feb 14, 2020D&A · Q1 2019: $12.0M · 10-Q 0001014473-19-000015 filed Apr 25, 2019D&A · Q2 2019: $11.0M · derived · 10-Q 0001014473-20-000029 filed Jul 23, 2020D&A · Q3 2019: $11.0M · derived · 10-Q 0001014473-20-000034 filed Oct 22, 2020D&A · Q4 2019: $12.0M · derived · 10-K 0001014473-21-000005 filed Feb 19, 2021D&A · Q1 2020: $11.0M · 10-Q 0001014473-20-000019 filed Apr 23, 2020D&A · Q2 2020: $12.0M · derived · 10-Q 0001014473-21-000023 filed Jul 22, 2021D&A · Q3 2020: $12.0M · derived · 10-Q 0001014473-21-000027 filed Oct 28, 2021D&A · Q4 2020: $12.0M · derived · 10-K 0001014473-22-000007 filed Feb 18, 2022D&A · Q1 2021: $12.0M · 10-Q 0001014473-22-000016 filed Apr 28, 2022D&A · Q2 2021: $12.0M · derived · 10-Q 0001014473-22-000023 filed Jul 28, 2022D&A · Q3 2021: $12.0M · derived · 10-Q 0001014473-22-000027 filed Oct 27, 2022D&A · Q4 2021: $12.0M · derived · 10-K 0001014473-23-000005 filed Feb 17, 2023D&A · Q1 2022: $12.0M · 10-Q 0001014473-22-000016 filed Apr 28, 2022D&A · Q2 2022: $12.0M · derived · 10-Q 0001014473-23-000033 filed Jul 27, 2023D&A · Q3 2022: $11.0M · derived · 10-Q 0001014473-23-000038 filed Oct 26, 2023D&A · Q4 2022: $12.0M · derived · 10-K 0001014473-24-000006 filed Feb 15, 2024D&A · Q1 2023: $12.0M · 10-Q 0001014473-23-000019 filed Apr 27, 2023D&A · Q2 2023: $11.0M · derived · 10-Q 0001014473-24-000033 filed Jul 25, 2024D&A · Q3 2023: $11.0M · derived · 10-Q 0001014473-24-000040 filed Oct 24, 2024D&A · Q4 2023: $10.0M · derived · 10-K 0001014473-25-000006 filed Feb 13, 2025D&A · Q1 2024: $10.0M · 10-Q 0001014473-24-000023 filed Apr 25, 2024D&A · Q2 2024: $9.0M · 10-Q 0001014473-25-000036 filed Jul 24, 2025D&A · Q3 2024: $9.0M · 10-Q 0001014473-25-000046 filed Oct 23, 2025D&A · Q4 2024: $9.0M · derived · 10-K 0001014473-26-000006 filed Feb 5, 2026D&A · Q1 2025: $9.0M · 10-Q 0001014473-25-000021 filed Apr 24, 2025D&A · Q2 2025: $8.0M · 10-Q 0001014473-25-000036 filed Jul 24, 2025D&A · Q3 2025: $7.0M · 10-Q 0001014473-25-000046 filed Oct 23, 2025D&A · Q4 2025: $7.0M · derived · 10-K 0001014473-26-000006 filed Feb 5, 2026D&A · Q1 2026: $6.0M · 10-Q 0001014473-26-000020 filed Apr 23, 2026D&A · Q2 2026: $7.0M · 10-Q 0001014473-26-000028 filed Jul 23, 202611.6a6.614.9Q1 2016Q2 2026Q3 2020
$MD&A · Q3 2019: $11.0M · derived · 10-Q 0001014473-20-000034 filed Oct 22, 2020D&A · Q4 2019: $12.0M · derived · 10-K 0001014473-21-000005 filed Feb 19, 2021D&A · Q1 2020: $11.0M · 10-Q 0001014473-20-000019 filed Apr 23, 2020D&A · Q2 2020: $12.0M · derived · 10-Q 0001014473-21-000023 filed Jul 22, 2021D&A · Q3 2020: $12.0M · derived · 10-Q 0001014473-21-000027 filed Oct 28, 2021D&A · Q4 2020: $12.0M · derived · 10-K 0001014473-22-000007 filed Feb 18, 2022D&A · Q1 2021: $12.0M · 10-Q 0001014473-22-000016 filed Apr 28, 2022D&A · Q2 2021: $12.0M · derived · 10-Q 0001014473-22-000023 filed Jul 28, 202211.6a12.0a11.4aQ3 2019Q2 2021Q3 2020
Q3 2020
11.6a$M
derived
All values (42)
PeriodValue ($M)Status
Q2 20266.6reported
Q1 20266.4reported
Q4 20256.7derived
Q3 20257.3reported
Q2 20258.3reported
Q1 20258.9reported
Q4 20248.8derived
Q3 20249.0reported
Q2 20249.3reported
Q1 20249.8reported
Q4 202310.4derived
Q3 202310.8derived
Q2 202311.3derived
Q1 202311.6reported
Q4 202211.7derived
Q3 202211.4derived
Q2 202211.9derived
Q1 202211.9reported
Q4 202112.3derived
Q3 202112.0derived
Q2 202112.0derived
Q1 202111.6reported
Q4 202011.9derived
Q3 202011.6derived
Q2 202011.6derived
Q1 202011.2reported
Q4 201912.0derived
Q3 201911.4derived
Q2 201911.3derived
Q1 201911.6reported
Q4 201811.9derived
Q3 201812.3derived
Q2 201812.1derived
Q1 201812.1reported
Q4 201712.2derived
Q3 201712.5derived
Q2 201712.1derived
Q1 201713.1reported
Q4 201614.1derived
Q3 201614.7derived
Q2 201614.6derived
Q1 201614.9reported

CSV with all sources · Technical ID: dna

More metrics for VeriSign

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$12.0M (derived)
Period
Q3 2020, ended Sep 30, 2020 · quarterly value (3 months, not cumulative)
Calculation
Q3 = 9 months kumuliert − 6 months kumuliert = 34M − 23M = $12.0M (us-gaap:DepreciationAndAmortization; 9-Monats-Wert aus 0001014473-21-000027, Vorperiode aus dem vorherigen 10-Q)
Source
10-Q, filed Oct 28, 2021 · 0001014473-21-000027
Location
us-gaap:DepreciationAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$12.0MOct 28, 202110-Q 0001014473-21-000027derived · confidence 1. · current